Evotec SE (MIL:1EVT)
€ 8.345 0 (0%) Market Cap: 1.52 Bil Enterprise Value: 1.61 Bil PE Ratio: 0 PB Ratio: 1.56 GF Score: 54/100

Preliminary Q4 2022 Evotec SE Earnings Call Transcript

Mar 28, 2023 / 12:00PM GMT
Operator

Ladies and gentlemen, thank you for standing by. Welcome and thank you for joining the Evotec SE Preliminary Figures Full Year 2022 Call. (Operator Instructions) The presentation will be followed by a question-and-answer session. (Operator Instructions) I would now like to turn the conference over to Dr. Werner Lanthaler, CEO. Please go ahead.

Werner Lanthaler
Evotec SE - Chairman of Management Board & CEO

Thank you very much. A warm welcome from sunny Hamburg to all listeners. And let me first remind you that we have uploaded a presentation for this call, which you can find on the Internet, and we have called it Ahead of the Curve: Leadership in our Focus Areas for Medicines that Matter. This brings me directly into how we wanted to start this discussion with you today, because it is amazing to see what we have achieved in 2022, and let me start by thanking the whole company who is working every day to find new medicines that matter.

Let me also thank you, my closest team. It's a big pleasure and a great satisfaction to go forward with you also

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot